Para su Difusión
Teva Removes Over 200 Improper Patent Listings Under Pressure from FTC
Fecha
After a challenge from the Federal Trade Commission, Teva Pharmaceuticals has requested that the Food and Drug Administration (FDA) remove more than 200 improper patent listings from the FDA’s Orange...